Claybrook Capital’s Illumina ILMN Stock Holding History

Claybrook Capital’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-79	Closed	-$23K	–	372
2018 Q4	$23K	Buy	+79	New	+$24.5K	0.01%	336

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Claybrook Capital's ILMN Position: Q1 2019 in Review

Claybrook Capital sold out of Illumina (ILMN) in Q1 2019, closing a stake of 79 shares — an estimated $23K sold.

Claybrook Capital first reported a position in ILMN in Q4 2018 and held it in 1 quarter. The position peaked at $23K in Q4 2018. 875 funds tracked by Wall St. Rank hold ILMN as of Q1 2019.

Claybrook Capital reported no remaining Illumina position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 79 Illumina shares in Q1 2019, an estimated $23K.
Claybrook Capital first reported a position in Illumina in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Illumina position peaked at $23K in Q4 2018.
875 funds tracked by Wall St. Rank held Illumina as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.